Trending Tickers: Full House Resorts Inc. (NASDAQ:FLL), Exact Sciences Corporation (NASDAQ:EXAS), Alcoa Inc. (NYSE:AA), Celldex Therapeutics, Inc. (NASDAQ:CLDX),

Full House Resorts Inc. (NASDAQ:FLL) announced that the Colorado Limited Gaming Control Commission has granted the Company licenses for its pending acquisition of Bronco Billy’s Casino and Hotel in Cripple Creek, Colorado. The Company expects to close on its acquisition of Bronco Billy’s before the end of the first quarter of 2016 once it has received all regulatory approvals, besides those from Colorado, and in conjunction with the refinancing of its primary debt.

Full House Resorts Inc. (NASDAQ:FLL) belongs to Services sector. Its net profit margin is -8.90% and weekly performance is 9.48%. On last trading day company shares ended up at $1.50. Full House Resorts Inc. (NASDAQ:FLL) distance from 50-day simple moving average (SMA50) is -1.03%.

On 24 February, Exact Sciences Corporation (NASDAQ:EXAS) announced that the company reported revenues of $39.4 million as a result of completing more than 104,000 Cologuard tests for full-year 2015. The company generated $14.4 million in revenues from approximately 38,000 completed Cologuard tests during the fourth quarter ended Dec. 31, 2015.

Exact Sciences Corporation (NASDAQ:EXAS) shares fell -1.19% in last trading session and ended the day at $5.80. EXAS Gross Margin is 23.80% and its return on assets is -48.50%. Exact Sciences Corporation (NASDAQ:EXAS) quarterly performance is -40.14%.

On 12 February, Alcoa Inc. (NYSE:AA) signed a long-term contract with GE Aviation through which they will supply nickel-based superalloys, titanium and aluminum for a broad range of engines. The contract is valued at more than $1.5 billion and will generate work for several Alcoa factories across the U.S.

On 25 February, Alcoa Inc. (NYSE:AA) shares increased 1.26% and was closed at $8.87. AA EPS growth in last 5 year was -20.80%. Alcoa Inc. (NYSE:AA) year to date (YTD) performance is -9.74%.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) said that, it continues to advance plans to expand the study of glembatumumab vedotin in other cancers in which gpNMB is expressed.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) ended the last trading day at $6.91. Company weekly volatility is calculated as 8.49% and price to cash ratio as 2.24. Celldex Therapeutics, Inc. (NASDAQ:CLDX) showed a weekly performance of -1.29%.

Lifetime Brands, Inc. (NASDAQ:LCUT) will release its fourth quarter 2015 financial results at 7:00 a.m. (Eastern time) on Friday, March 11, 2016. The Company has scheduled a conference call for 11:00 a.m., at which time Jeffrey Siegel, Chairman and Chief Executive Officer, and Laurence Winoker, Senior Vice President and Chief Financial Officer, will discuss the Company’s financial results and will be available to answer investor questions.

Lifetime Brands, Inc. (NASDAQ:LCUT) shares increased 0.60% in last trading session and ended the day at $11.75. LCUT Gross Margin is 36.30% and its return on assets is 2.50%. Lifetime Brands, Inc. (NASDAQ:LCUT) quarterly performance is -11.66%.

Leave a Reply

Your email address will not be published. Required fields are marked *